1M6MYTD1Y5YMAX
Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | 2024 | |
|---|---|---|
| Revenue | 23.13M | 212.11% |
| Gross profit | 23.13M | 11.43% |
| Net profit | 22.54M | 24.48% |
| EBITDA | 891.03K | 95.08% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €1.47B |
Number of shares | 101.26M |
52-week high/low | €14.84 - €11.78 |
Dividend yield | 8.15% |
Dividends TTM | €1.18 |
Next dividend | €0.0946 |
Beta | 0.84 |
P/E ratio | 9.53 |
PEG ratio | 0.10 |
P/B ratio | 0.29 |
P/S ratio | 70.98 |
Company profile
| Name | Blackrock Health Sciences Trust II (50807051) |
| CEO | John Perlowski |
| Headquarters | New York,
ny USA |
| Website | |
| IPO | 01/29/2020 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NYSE | BMEZ |
Discover assets
Shareholders of Blackrock Health Sciences Trust II (50807051) also invest in the following assets
